GW766944

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GW766944, covering 2017-04-13 to 2017-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Oral GW766944 (Oral CCR3 Antagonist) [Phase 2]